OMASPLEA

Welcome to the Brand page for “OMASPLEA”, which is offered here for Pharmaceutical preparations for the treatment of endothelial diseases and disorders, renal diseases, transplant complications, ischemia-reperfusion injury and hematological, autoimmune, neurological, immunological and inflammation-related disease and disorders; biologics for the treatment of endothelial diseases and disorders, renal diseases, transplant complications, ischemia-reperfusion injury and hematological, autoimmune, neurological, immunological and inflammation-related disease and disorders;.

Its status is currently believed to be active. Its class is unavailable. “OMASPLEA” is believed to be currently owned by “Omeros Corporation”.